Jeffrey M. Dayno, PRESIDENT, CEO at Harmony Biosciences Holdings, Inc. (HRMY), sold 31,866 shares at $40.11 ($1.3M) on 2025-12-12, disclosed to the SEC on 2025-12-17.
Scheduled sale ($1.3M) by PRESIDENT, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.11 | 5,933 | $238K | 18.6% |
| 2 | $40.11 | 5,933 | $238K | 18.6% |
| 3 | $40.11 | 20,000 | $802K | 62.8% |
| Total | $40.11 avg | 31,866 | $1.3M | 100% |
| Filing → |
| HRMY | SELL | 2022-11-02 | $827K | — | Filing → |
| HRMY | SELL | 2021-10-20 | $1.6M | — | Filing → |
| HRMY | SELL | 2021-10-07 | $72K | — | Filing → |